Brief report: Attention deficit and hyperactivity disorder scores are elevated and respond to N-Acetylcysteine treatment in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 65, Issue 5, 2013, Pages 1313-1318

  Garcia, Ricardo J ^a   Francis, Lisa ^a   Dawood, Maha ^a   Lai, Zhi Wei ^a   Faraone, Stephen V ^a   Perl, Andras ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; PLACEBO; SCAVENGER;

ADHD SELF REPORT SCALE; ARTICLE; ATTENTION DEFICIT DISORDER; BRITISH ISLES LUPUS ASSESSMENT GROUP INDEX; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DRUG EFFECT; FATIGUE ASSESSMENT SCALE; HUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; ADULT; AGED; CONTROLLED CLINICAL TRIAL; EARLY DIAGNOSIS; FEMALE; HEALTH STATUS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ACETYLCYSTEINE; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; EARLY DIAGNOSIS; FEMALE; FREE RADICAL SCAVENGERS; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; SELF REPORT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

MLCS; MLOWN;

EID: 84876535307     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37893     Document Type: Article

References (15)

1. Francis L, Perl A,. Pharmacotherapy of systemic lupus erythematosus. Expert Opin Pharmacother 2009; 10: 1481-94.
2. Gergely PJ Jr, Grossman C, Niland B, Puskas F, Neupane H, Allam F, et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 2002; 46: 175-90.
3. Lai ZW, Hanczko R, Bonilla E, Caza TN, Clair B, Bartos A, et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2012; 64: 2937-46.
4. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
5. Martinez M, Hernandez AI, Martinez N,. N-acetylcysteine delays age-associated memory impairment in mice: role in synaptic mitochondria. Brain Res 2000; 855: 100-6.
6. Bernardo M, Dodd S, Gama CS, Copolov DL, Dean O, Kohlmann K, et al. Effects of N-acetylcysteine on substance use in bipolar disorder: a randomised placebo-controlled clinical trial. Acta Neuropsychiatr 2009; 21: 239-45.
7. Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia: a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 2008; 64: 361-8.
8. Biederman J, Petty CR, Monuteaux MC, Fried R, Byrne D, Mirto T, et al. Adult psychiatric outcomes of girls with attention deficit hyperactivity disorder: 11-year follow-up in a longitudinal case-control study. Am J Psychiatry 2010; 167: 409-17.
9. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005; 35: 245-56.
10. Adler LA, Spencer T, Faraone SV, Kessler RC, Howes MJ, Biederman J, et al. Validity of pilot Adult ADHD Self-Report Scale (ASRS) to rate adult ADHD symptoms. Ann Clin Psychiatry 2006; 18: 145-8.
11. Isenberg DA, Rahman A, Allen E, Farewell V, Akil M, Bruce IN, et al. BILAG 2004: development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44: 902-6.
12. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
13. Michielsen HJ, De Vries J, Van Heck GL,. Psychometric qualities of a brief self-rated fatigue measure: the Fatigue Assessment Scale. J Psychosom Res 2003; 54: 345-52.
14. Muzykewicz DA, Newberry P, Danforth N, Halpern EF, Thiele EA,. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav 2007; 11: 506-13.
15. Faraone SV, Glatt SJ,. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010; 71: 754-63.